202 related articles for article (PubMed ID: 23029077)
1. MAGEB2 is activated by promoter demethylation in head and neck squamous cell carcinoma.
Pattani KM; Soudry E; Glazer CA; Ochs MF; Wang H; Schussel J; Sun W; Hennessey P; Mydlarz W; Loyo M; Demokan S; Smith IM; Califano JA
PLoS One; 2012; 7(9):e45534. PubMed ID: 23029077
[TBL] [Abstract][Full Text] [Related]
2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
3. Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.
Smith IM; Glazer CA; Mithani SK; Ochs MF; Sun W; Bhan S; Vostrov A; Abdullaev Z; Lobanenkov V; Gray A; Liu C; Chang SS; Ostrow KL; Westra WH; Begum S; Dhara M; Califano J
PLoS One; 2009; 4(3):e4961. PubMed ID: 19305507
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
Chaisaingmongkol J; Popanda O; Warta R; Dyckhoff G; Herpel E; Geiselhart L; Claus R; Lasitschka F; Campos B; Oakes CC; Bermejo JL; Herold-Mende C; Plass C; Schmezer P
Oncogene; 2012 Dec; 31(49):5108-16. PubMed ID: 22286769
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological genome demethylation increases radiosensitivity of head and neck squamous carcinoma cells.
Brieger J; Mann SA; Pongsapich W; Koutsimpelas D; Fruth K; Mann WJ
Int J Mol Med; 2012 Mar; 29(3):505-9. PubMed ID: 22109647
[TBL] [Abstract][Full Text] [Related]
6. Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling.
Demokan S; Chuang AY; Chang X; Khan T; Smith IM; Pattani KM; Dasgupta S; Begum S; Khan Z; Liegeois NJ; Westra WH; Sidransky D; Koch W; Califano JA
Int J Oncol; 2013 Apr; 42(4):1427-36. PubMed ID: 23403885
[TBL] [Abstract][Full Text] [Related]
7. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
[TBL] [Abstract][Full Text] [Related]
8. Validation of nucleolar protein 4 as a novel methylated tumor suppressor gene in head and neck cancer.
Demokan S; Chuang AY; Pattani KM; Sidransky D; Koch W; Califano JA
Oncol Rep; 2014 Feb; 31(2):1014-20. PubMed ID: 24337411
[TBL] [Abstract][Full Text] [Related]
9. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
[TBL] [Abstract][Full Text] [Related]
10. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
11. Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.
Bennett KL; Hackanson B; Smith LT; Morrison CD; Lang JC; Schuller DE; Weber F; Eng C; Plass C
Cancer Res; 2007 May; 67(10):4657-64. PubMed ID: 17510391
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.
Cao W; Zhang ZY; Xu Q; Sun Q; Yan M; Zhang J; Zhang P; Han ZG; Chen WT
Mol Cancer; 2010 Nov; 9():296. PubMed ID: 21092172
[TBL] [Abstract][Full Text] [Related]
13. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic silencing of CRABP2 and MX1 in head and neck tumors.
Calmon MF; Rodrigues RV; Kaneto CM; Moura RP; Silva SD; Mota LD; Pinheiro DG; Torres C; de Carvalho AF; Cury PM; Nunes FD; Nishimoto IN; Soares FA; da Silva AM; Kowalski LP; Brentani H; Zanelli CF; Silva WA; Rahal P; Tajara EH; Carraro DM; Camargo AA; Valentini SR
Neoplasia; 2009 Dec; 11(12):1329-39. PubMed ID: 20019841
[TBL] [Abstract][Full Text] [Related]
15. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
17. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
[TBL] [Abstract][Full Text] [Related]
18. Transporter gene expression in human head and neck squamous cell carcinoma and associated epigenetic regulatory mechanisms.
Zolk O; Schnepf R; Muschler M; Fromm MF; Wendler O; Traxdorf M; Iro H; Zenk J
Am J Pathol; 2013 Jan; 182(1):234-43. PubMed ID: 23137910
[TBL] [Abstract][Full Text] [Related]
19. Promoter methylation in head and neck squamous cell carcinoma cell lines is significantly different than methylation in primary tumors and xenografts.
Hennessey PT; Ochs MF; Mydlarz WW; Hsueh W; Cope L; Yu W; Califano JA
PLoS One; 2011; 6(5):e20584. PubMed ID: 21637785
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of loss of human esophageal cancer-related gene 4 (ECRG4) gene expression in esophageal squamous cell carcinoma cell line EC9706].
Li LW; Yu XY; Li XY; Guo LP; Zhou Y; Lu SX
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):570-3. PubMed ID: 22325214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]